CVS Group Plc (LON:CVSG) had its target price upped by investment analysts at Investec from GBX 995 ($12.34) to GBX 1,085 ($13.46) in a note issued to investors on Monday. The firm presently has an “add” rating on the stock. Investec’s target price indicates a potential upside of 2.17% from the company’s current price.

A number of other research analysts also recently issued reports on CVSG. Berenberg Bank boosted their price target on shares of CVS Group Plc from GBX 910 ($11.29) to GBX 1,000 ($12.41) and gave the stock a “buy” rating in a research report on Thursday, October 20th. N+1 Singer restated a “corporate” rating on shares of CVS Group Plc in a research report on Friday, September 23rd. Finally, Peel Hunt downgraded shares of CVS Group Plc to an “add” rating and boosted their price target for the stock from GBX 950 ($11.79) to GBX 1,000 ($12.41) in a research report on Friday, September 23rd.

CVS Group Plc (LON:CVSG) opened at 1069.00 on Monday. The firm’s market capitalization is GBX 641.38 million. The stock’s 50 day moving average is GBX 883.89 and its 200-day moving average is GBX 842.10. CVS Group Plc has a 12 month low of GBX 645.00 and a 12 month high of GBX 1,075.00.

The business also recently disclosed a dividend, which will be paid on Friday, December 9th. Stockholders of record on Thursday, November 24th will be paid a GBX 3.50 ($0.04) dividend. The ex-dividend date is Thursday, November 24th. This represents a dividend yield of 0.37%. This is a positive change from CVS Group Plc’s previous dividend of $3.00.

COPYRIGHT VIOLATION NOTICE: “CVS Group Plc (CVSG) PT Raised to GBX 1,085” was posted by Financial Market News and is the sole property of of Financial Market News. If you are reading this story on another publication, it was illegally copied and republished in violation of United States & international copyright law. The legal version of this story can be viewed at http://www.financial-market-news.com/cvs-group-plc-cvsg-pt-raised-to-gbx-1085/1209900/.

In related news, insider Mike McCollum acquired 23,328 shares of the stock in a transaction dated Monday, October 24th. The stock was bought at an average price of GBX 877 ($10.88) per share, for a total transaction of £204,586.56 ($253,797.99). Also, insider Richard A. Connell acquired 2,109 shares of the stock in a transaction dated Friday, October 28th. The stock was bought at an average price of GBX 878 ($10.89) per share, with a total value of £18,517.02 ($22,971.12).

About CVS Group Plc

CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals.

Receive News & Ratings for CVS Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.